Manjula Singh
Indian Council of Medical Research
Scientist E, Division of Epidemiology and Communicable Diseases
Dr. Manjula Singh, is Scientist E (Deputy Director General), Division of Epidemiology and Communicable Diseases, at Indian Council of Medical Research (ICMR), New Delhi, India. She is a Medical Doctor with Ph.D in ‘Immunology’ and training in Dermatology, Venereology and Leprology.
She has a vast experience of more than 18 years in the area of Tuberculosis, leprosy & HIV research and has been involved in many clinical trials in these areas. Currently she is the Programme Officer for tuberculosis research at ICMR including Indo-US collaboration on tuberculosis research and is the co-ordinator of several clinical and implementation research studies on TB.
She is a member of National Technical Resource Group of National TB Elimination Programme (NTEP), Central TB Division under Ministry of Health & family Welfare, Government of India and has also served as member of WHO’s Global Task Force on TB Research. She is the coordinator of TB research activities of the ‘BRICS TB research network’ from ICMR and is involved in planning and executing multicountry research activities among BRICS countries.
She is the key person involved in the establishment and co-ordination of activities under ‘India TB Research consortium’ (ITRC), a flagship programme of ICMR focussed on development of new tools and strategies in four thematic areas (diagnostics, therapeutics, vaccines and implementation research) of TB research to tackle TB in a mission mode which has won the prestigious International ‘KOCHON Prize’ 2017 for accelerating TB R&D in the country. She is co-ordinating several studies on newer drug regimen, newer diagnostics and implementation strategies under ITRC. She is currently leading the Phase III TB vaccine trial with two vaccines for prevention of TB in healthy household contacts of TB cases.
She has won the ‘BMJ infectious disease initiative of the year in 2018’ and National e-Governance award, 2019 by Ministry of Public Reforms & Public Grievances, Government of India for ‘Outstanding research on citizen centric services’ by research Institutions for undertaking the multicentric research of mobile TB diagnostics van intervention in tribal areas in 5 states of India through ICMR Institutes.
Manjula Singh
Indian Council of Medical Research
Scientist E, Division of Epidemiology and Communicable Diseases
Dr. Manjula Singh, is Scientist E (Deputy Director General), Division of Epidemiology and Communicable Diseases, at Indian Council of Medical Research (ICMR), New Delhi, India. She is a Medical Doctor with Ph.D in ‘Immunology’ and training in Dermatology, Venereology and Leprology.
She has a vast experience of more than 18 years in the area of Tuberculosis, leprosy & HIV research and has been involved in many clinical trials in these areas. Currently she is the Programme Officer for tuberculosis research at ICMR including Indo-US collaboration on tuberculosis research and is the co-ordinator of several clinical and implementation research studies on TB.
She is a member of National Technical Resource Group of National TB Elimination Programme (NTEP), Central TB Division under Ministry of Health & family Welfare, Government of India and has also served as member of WHO’s Global Task Force on TB Research. She is the coordinator of TB research activities of the ‘BRICS TB research network’ from ICMR and is involved in planning and executing multicountry research activities among BRICS countries.
She is the key person involved in the establishment and co-ordination of activities under ‘India TB Research consortium’ (ITRC), a flagship programme of ICMR focussed on development of new tools and strategies in four thematic areas (diagnostics, therapeutics, vaccines and implementation research) of TB research to tackle TB in a mission mode which has won the prestigious International ‘KOCHON Prize’ 2017 for accelerating TB R&D in the country. She is co-ordinating several studies on newer drug regimen, newer diagnostics and implementation strategies under ITRC. She is currently leading the Phase III TB vaccine trial with two vaccines for prevention of TB in healthy household contacts of TB cases.
She has won the ‘BMJ infectious disease initiative of the year in 2018’ and National e-Governance award, 2019 by Ministry of Public Reforms & Public Grievances, Government of India for ‘Outstanding research on citizen centric services’ by research Institutions for undertaking the multicentric research of mobile TB diagnostics van intervention in tribal areas in 5 states of India through ICMR Institutes.